The role of serum interleukin-6 level in predicting the postoperative complications after ovarian cancer surgery
Not Applicable
- Conditions
- Health Condition 1: null- carcinoma ovaryHealth Condition 2: C569- Malignant neoplasm of unspecifiedovary
- Registration Number
- CTRI/2018/04/013162
- Lead Sponsor
- Dr Vibhavari Naik
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All Carcinoma Ovary patients posted for ovarian cytoreduction surgery will be included
Exclusion Criteria
Patients posted for emergency procedures will be excluded
Patients who refuse to consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mortality <br/ ><br>ComplicationsTimepoint: During hospital stay
- Secondary Outcome Measures
Name Time Method ength of ICU stay <br/ ><br>Length of Hospital stayTimepoint: During hospital stay